Rare or Unverified Outcomes Shape Vaccine Safety and Gender Care Debates Joel Luther , Hagere Yilma , and Irving Washington

https://www.kff.org/health-information-trust/rare-or-unverified-outcomes-shape-vaccine-safety-and-gender-care-debates/?utm_campaign=22234741-KFF-Information-Trust&utm_medium=email&_hsenc=p2ANqtz--bHoVBEgJy5Ad6vB_PoOMS0GYnbmgn4sZHJXVHMRJKeJh1cLNT3aTFpeNtBJS9zGdQX_R1R8rCsZZwOOpRmdxuU84o2g&_hsmi=423344636&utm_content=423344636&utm_source=hs_email Two recent federal actions, including a memo about alleged COVID-19 vaccine deaths and settlements creating a “detransition clinic,” show how official actions can present uncertain or uncommon outcomes as representative and lend credibility to narratives that go beyond what evidence supports. What We're Watching Official Actions Elevate Uncertain or Uncommon Outcomes in Debates Over Vaccine Safety and Gender-Affirming Care Official actions can elevate unverified or uncommon outcomes in ways that shape public perceptions beyond what evidence suggests. Two developments show how such actions can lend weight to narratives not borne out by evidence, one by overstating a causal link not supported by data, and the other by creating an institution based on a premise research does not support. FDA Analysis of Pediatric Deaths After COVID Vaccination Shows Weaker Link Than Officials Claimed A small number of unverified reports became the basis for a claim of definitive, widespread harm when, last November, then-FDA vaccine chief Vinay Prasad told agency staff in an internal memo that at least 10 children had died "after and because of" receiving a COVID-19 vaccine, using that claim to argue for changes to vaccine approval and oversight. The underlying analysis made public last month, however, found no deaths definitively linked to COVID-19 vaccination. The FDA reviewed 96 reports of child deaths submitted to the Vaccine Adverse Event Reporting System (VAERS) through August 2025. Using WHO criteria and reviews of medical records and death certificates, officials concluded that none were "certain" to be linked to vaccination. Five were classified as "possible" and two as "probable,” but the report notes alternative explanations could not be ruled out. Most cases involved myocarditis, a rare heart inflammation that can also be caused by common infections, including COVID-19 itself. The original memo presented preliminary findings with a certainty the underlying data did not support and did not reflect the limitations of VAERS, which is not intended to establish causality. The communication of vaccine safety information may be especially consequential at a time when confidence in COVID-19 vaccine safety remains lower than confidence in other childhood vaccines: KFF's January Tracking Poll on Health Information and Trust found that eight in ten (81%) adults expressed confidence in the safety of MMR vaccines for children, compared to fewer than half (48%) who said the same about COVID-19 vaccines, though views of the COVID-19 vaccines are largely partisan. Settlements Create “Detransition Clinic” Amid Narratives That Overstate Transition Regret New efforts related to gender-affirming care for minors have presented cases of “detransition” or transition regret as representative of broader outcomes or a pattern of harm, though research finds both to be uncommon outcomes. Claims about “irreversible harm” often rely on inflated statistics, anecdotal stories, or misleading characterizations of surgeries for minors, which are rare and generally not recommended for younger adolescents. While some transgender people do choose to detransition, specialized clinics are not required to support this care. Legal settlements reached last month between Texas Children’s Hospital, the Texas attorney general, and the U.S. Department of Justice may implicitly reinforce those narratives by creating what state officials called the country’s first “detransition clinic,” a facility for patients who want to stop or reverse a gender transition. The creation of such a clinic contrasts with research about gender-affirming care in practice. Many youth transition by making easily reversible social changes, like changes in clothing, names, or pronouns. Among transgender people who pursue medical transition, detransition is uncommon and transition regret rates are low. Many who do detransition cite pressure and discrimination rather than regret or a change in gender identity. Major medical associations continue to support gender-affirming care for minors when delivered carefully and with clinical oversight. By creating a dedicated clinic, the settlements may reinforce narratives that frame regret and detransition as common outcomes. Additionally, DOJ’s involvement adds to the pressure providers have experienced in the face of a range of administration actions aimed at limiting this care, with effects potentially extending beyond Texas. At least 40 health care institutions have walked back such services since January 2025, generally citing external pressure rather than concerns about safety or effectiveness. Why It Matters: When unrepresentative or unconfirmed cases are presented through official channels as representative of broader patterns of harm, they can appear to carry a credibility that the underlying evidence does not support.